On the stock market since 2019, it operates in the world of money and finance. It has 23 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Average growth of 14% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Bets Against the Stock: The number of investors betting on a fall stands out.
The stock trades 51% below its peak. The market has trimmed its expectations for the company.
Sales run at $22.3M a year. A small number, but proof the product has real buyers.
It pays out $2.57 per share each year — regular cash for whoever holds the stock.
A loss of $2.5M against $22.3M in annual sales.
Over the last 12 months, executives reported 8 sells against just 0 buys. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, PPHI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: PPHI is a high-risk stock — not yet profitable, and its future rides on its product catching on.